Proprietary Products — Net Sales
West Pharmaceutical Services Proprietary Products — Net Sales increased by 4.9% to $694.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.3%, from $563.00M to $694.30M. Over 2 years (FY 2023 to FY 2025), Proprietary Products — Net Sales shows relatively stable performance with a 2.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates strong market adoption and pricing power for proprietary solutions, while a decrease may signal competitive pressure or reduced pharmaceutical industry demand.
Detailed definition
This metric represents the total revenue generated from the sale of proprietary pharmaceutical packaging and delivery co...
Peer comparison
Comparable to net sales of specialized medical device or pharmaceutical component segments at peer life sciences companies.
wst_segment_proprietary_products_net_salesHistorical Data
| Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $601.30M | $653.70M | $583.10M | $618.00M | $602.50M | $593.70M | $559.50M | $559.70M | $601.40M | $613.90M | $563.00M | $619.80M | $647.50M | $661.80M | $694.30M |
| QoQ Change | — | +8.7% | -10.8% | +6.0% | -2.5% | -1.5% | -5.8% | +0.0% | +7.5% | +2.1% | -8.3% | +10.1% | +4.5% | +2.2% | +4.9% |
| YoY Change | — | — | -3.0% | -5.5% | — | — | -4.0% | -9.4% | -0.2% | +3.4% | +0.6% | +10.7% | +7.7% | +7.8% | +23.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's proprietary products — net sales?
- West Pharmaceutical Services (WST) reported proprietary products — net sales of $694.30M in Q1 2026.
- How has West Pharmaceutical Services's proprietary products — net sales changed year-over-year?
- West Pharmaceutical Services's proprietary products — net sales increased by 23.3% year-over-year, from $563.00M to $694.30M.
- What is the long-term trend for West Pharmaceutical Services's proprietary products — net sales?
- Over 2 years (2023 to 2025), West Pharmaceutical Services's proprietary products — net sales has grown at a 2.0% compound annual growth rate (CAGR), from $2.40B to $2.49B.
- What does proprietary products — net sales mean?
- Total revenue earned from the company's own branded pharmaceutical products.